您当前位置：首页 > 国际期刊-Asian Pacific Journal of Cancer Prevention期刊投稿发表详细信息

Asian Pacific Journal of Cancer Prevention Q0

期刊收录：
Scopus
DOAJ

基本信息

期刊ISSN：
1513-7368
期刊简拼：
ASIAN PAC J CANCER P
年发文章数：
1385
E-ISSN：
2476-762X
Gold OA文章占比
0.00%
研究文章占比：
0.00%
是否OA：
Yes
Jcr分区：
Q0
中科院分区：

出版信息

出版商：
Asian Pacific Organization for Cancer Prevention
涉及研究方向：
医学-肿瘤学
出版国家：
JAPAN
出版语言：
English
出版周期：
Quarterly
出版年份：
2000

2023-2024最新影响因子:0
自引率:N.A.
五年影响因子:0
JCI期刊引文指标:0
h-index:65
CiteScore:2.80

期刊关键词

0区 Scopus DOAJ

期刊简介

Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.

The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally.

The APJCP publishes original research results under the following categories:

-Epidemiology, detection and screening.
-Cellular research and bio-markers.
-Identification of bio-targets and agents with novel mechanisms of action.
-Optimal clinical use of existing anti-cancer agents, including combination therapies.
-Radiation and surgery.
-Palliative care.
-Patient adherence, quality of life, satisfaction.
-Health economic evaluations.

《Asian Pacific Journal of Cancer Prevention》期刊已被查看：次
期刊简写：ASIAN PAC J CANCER P

此期刊未被最新的JCR期刊引证报告收录